Search
+
    SEARCHED FOR:

    PULMONARY EMBOLISM

    Alembic gets USFDA nod for generic medication

    Alembic Pharmaceuticals announced approval from the USFDA to market Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis prophylaxis, equivalent to Pradaxa Capsules. The company now has 211 ANDA approvals. Shares closed 3.17% lower at Rs 1,076 on the BSE.

    Samantha Ruth Prabhu called ‘health illiterate’ by ‘Liver Doc’ for suggesting hydrogen peroxide therapy. ‘Kushi’ star reacts

    Samantha Ruth Prabhu has sparked controversy within the medical community on X. The Ye Maaya Chesave actress recently advised her followers to try the hydrogen peroxide inhalation protocol for viral fevers. However, this recommendation faced strong backlash from Dr. Cyriac Abby Philips, a hepatologist known as 'The Liver Doctor' on X, who criticized the Yasoda star and labeled her "health and science illiterate. "

    Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsules

    Alembic Pharmaceuticals Ltd received final approval from the US health regulator for generic Dabigatran Etexilate capsules 75 mg and 150 mg to reduce stroke and blood clots in adults with a specific medical condition.

    Snake venom can kill.... but it can also heal!

    Snake venom hit headlines after YouTuber Elvish Yadav was arrested for selling snake poison at rave parties. Despite the bad reputation and long association with death and malaise, snake venom has been used to develope life saving drugs!

    Brazilian reality star Luana Andrade dies at 29 after liposuction surgery goes wrong

    The surgery was abruptly halted after two and a half hours when Andrade suffered a cardiac arrest and subsequently tested positive for a massive thrombosis.

    World Thrombosis Day: From losing weight to reducing stress, 4 ways to keep blood clots at bay

    Every year, World Thrombosis Day is observed on October 13. The International Society on Thrombosis and Haemostasis has set aside this day, to create more awareness about this health condition.

    The Economic Times
    BACK TO TOP